Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 8669285 was granted and assigned to Reviva Pharmaceuticals on March, 2014 by the United States Patent and Trademark Office. | 8669285 | March 11, 2014 | |||||||
Patent 8247420 was granted and assigned to Reviva Pharmaceuticals on August, 2012 by the United States Patent and Trademark Office. | 8247420 | August 21, 2012 | |||||||
Patent 8431570 was granted and assigned to Reviva Pharmaceuticals on April, 2013 by the United States Patent and Trademark Office. | 8431570 | April 30, 2013 | |||||||
Patent 8372883 was granted and assigned to Reviva Pharmaceuticals on February, 2013 by the United States Patent and Trademark Office. | 8372883 | February 12, 2013 | |||||||
Patent 7989500 was granted and assigned to Reviva Pharmaceuticals on August, 2011 by the United States Patent and Trademark Office. | 7989500 | August 2, 2011 | |||||||
Patent 8247563 was granted and assigned to Reviva Pharmaceuticals on August, 2012 by the United States Patent and Trademark Office. | 8247563 | August 21, 2012 | |||||||
Patent 8580822 was granted and assigned to Reviva Pharmaceuticals on November, 2013 by the United States Patent and Trademark Office. | 8580822 | November 12, 2013 | |||||||
Patent 8445714 was granted and assigned to Reviva Pharmaceuticals on May, 2013 by the United States Patent and Trademark Office. | 8445714 | May 21, 2013 | |||||||
Patent 8461154 was granted and assigned to Reviva Pharmaceuticals on June, 2013 by the United States Patent and Trademark Office. | 8461154 | June 11, 2013 | |||||||
Patent 8188076 was granted and assigned to Reviva Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office. | 8188076 | May 29, 2012 | |||||||
Patent 8207163 was granted and assigned to Reviva Pharmaceuticals on June, 2012 by the United States Patent and Trademark Office. | 8207163 | June 26, 2012 | |||||||
8575185 | November 5, 2013 | ||||||||
Patent 8604244 was granted and assigned to Reviva Pharmaceuticals on December, 2013 by the United States Patent and Trademark Office. | 8604244 | December 10, 2013 | |||||||
8338632 | December 25, 2012 |